# Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative Pneumonia

> **NCT01969799** · PHASE2 · COMPLETED · sponsor: **Cardeas Pharma** · enrollment: 143 (actual)

## Conditions studied

- Pneumonia, Bacterial

## Interventions

- **DRUG:** Amikacin fosfomycin inhalation solution
- **DRUG:** Aerosolized placebo

## Key facts

- **NCT ID:** NCT01969799
- **Lead sponsor:** Cardeas Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-12
- **Primary completion:** 2016-03
- **Final completion:** 2016-04
- **Target enrollment:** 143 (ACTUAL)
- **Last updated:** 2017-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01969799

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01969799, "Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative Pneumonia". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01969799. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*